Solutions and treatments

FOR WOMEN

- Intrauterine insemination (IUI)
- In vitro fertilisation (IVF)
- Induction of ovulation
Artificial insemination, or IUI, is a common fertility treatment used for various fertility problems. This method is considered less invasive than some MAP (Medically Assisted Reproduction) techniques, since the crucial steps necessary for conception must occur naturally, without any medical assistance.
What happens during the IUI
- During a gynaecological examination, the doctor inserts a thin, flexible catheter into the patient's cervix to deposit a sperm sample in her uterus. This insertion is painless and the patient can resume her daily activities within minutes.
- Semen introduced into the patient's uterus was washed in the laboratory to remove seminal fluid and make it more concentrated.
- The sperm can come from the spouse (intra-couple artificial insemination or with the spouse's sperm, IAC) or from a donor (artificial insemination with donor, IAD).
Indications for IUI using the spouse's sperm
- Male infertility problems associated with low sperm count or disorders of sperm motility or morphology.
- Male infertility following cancer treatment (where the patient, in anticipation of this problem, has had his sperm frozen prior to the start of treatment).
- Repeated failure of ovarian stimulation.
- Unexplained infertility.
Indications for IUI using donor sperm
- Major sperm abnormality, such as a complete absence of sperm.
- Inherited genetic diseases or contagious diseases that could be passed on to the spouse.
- Isolation or other problems.
- Male infertility following cancer treatment.
By definition, artificial insemination deposits sperm in the woman's uterus. In vitro fertilisation (IVF) goes beyond this procedure by fertilising the woman's egg with the man's sperm outside the woman's body. The term "test tube babies" is a synonym for IVF.
Since 1978, the year Louise Brown (the first person to be born as a result of IVF) was born in Great Britain, the technique has gone far beyond its original indication of treating tubal infertility. Today, more than half of all IVF procedures are performed for other reasons, for example, to treat unexplained infertility and to increase the chances of success in cases of male infertility.
For most people, IVF is simply the joining of two gametes in a test tube. But for couples who have decided to undergo IVF treatment, the process involves countless clinic appointments, blood tests and injections, as well as constant questions and encouragement and a lot of waiting. Waiting for the test results, waiting for the embryos, waiting for the pregnancy test, waiting for a child to come into their lives.
Couples undergoing IVF treatment face several challenges, including learning all about the procedure, which includes a lot of information to digest that is not always easy to understand. Before you decide to undergo treatment, we suggest that you learn as much as possible about IVF treatment by consulting your doctor and researching the many books and websites that exist on the subject. Being well informed about everything involved in the procedure will give you peace of mind when you start your IVF treatment.
Preliminary stages of IVF
You and your partner will meet with one of our doctors. At this time, you will receive your diagnosis and discuss with your doctor whether IVF is the best treatment for your particular situation.
Once you have decided to undergo IVF, a baseline assessment will be carried out, as well as several other meetings, appointments and tests:
- A consultation with a fertility counsellor or psychologist.
- Another appointment with your doctor to work out your plan for IVF.
- A meeting with your nurse, during which the nurse will review with you all the information relating to each stage of treatment. She will also give you your medication and explain the treatment schedule and how to take your medication.
- Consultation with the urologist if epididymal sperm aspiration or testicular sperm extraction is required. It may also be necessary to take a blood sample for genetic analysis. Patients can have these tests done at the Procrea Fertility Clinic or choose another clinic.
All of these preliminary steps help you to prepare for IVF by correcting any identified problems and providing you with all the information you need to understand the process. The steps of the IVF process are explained below.
Step 1: Ovarian suppression
The first step is to suppress ovarian function by administering an oral contraceptive and/or a drug that inhibits the pituitary gland. This step is not always required and your doctor will determine whether or not it is necessary in your case. During the suppression phase, estrogen levels become low, as in menopause, resulting in some similar side effects, such as hot flashes and mood changes. This stage (if determined to be the best choice for you) allows us to replace your natural cycle with an artificial cycle, which is then controlled with prescribed medication.
Second step: Ovarian stimulation
(superovulation)/controlled ovarian hyperstimulation (COH)
Ovarian suppression is achieved when estradiol levels are sufficiently low, as described in step 1. At this point, ovarian stimulation can be started to establish an 'artificial cycle'. Your ovaries usually produce and release only one egg per cycle. Although this is sufficient for natural conception, IVF conception usually requires several eggs.
To obtain more than one, ovarian hyperstimulation is used. These drugs stimulate the development of several ovarian follicles, allowing the retrieval of several eggs.
- Estradiol level: this blood test is used as an indicator of your response to medication.
- Luteinizing Hormone (LH): This hormone needs to be suppressed to prevent your body from releasing eggs too soon.
- Transvaginal ultrasound: this is used to check the number and diameter of follicles that have developed during ovarian stimulation.
Stage 3: Initiation of the egg maturation process
When the follicles are large enough and hormone levels are adequate, it is time to trigger the ovaries to prepare the eggs for maturation and ovulation. Triggering is done by injecting human chorionic gonadotropin (hCG, a pregnancy hormone similar to LH) or a recombinant hormone.
Step 4: Egg/oocyte retrieval (also called egg collection)
The eggs are retrieved transvaginally using ultrasound guidance. Once the mature follicles are located, the doctor punctures each one with a needle attached to the probe and sucks out the fluid. You will be given a local anaesthetic or sedative by intravenous (IV) infusion. If you wish, you can follow the procedure on the ultrasound screen. The embryologist analyses the contents of each follicle under the microscope. When the procedure is complete, you will be informed of the total number of eggs collected. On the same day, these eggs will be brought into contact with in vitro spermatozoa in order to be fertilised and subsequently form embryos.
Step 5: Embryo transfer
Embryo transfer involves depositing one or more embryos (usually one) inside the patient's uterine cavity, usually on day 5 of the cycle.This procedure requires the patient's bladder to be filled so that better visualisation can be achieved with the abdominal ultrasound probe.
What next?
Waiting for the pregnancy test is often the most anxious time for patients undergoing IVF treatment. A blood test is carried out 12 days after the transfer; this test accurately detects the pregnancy hormone (hCG) in your blood. You will be called on the same day with the result, which we hope will be positive.
- You have ovulation problems that have not responded to commonly prescribed medications (such as clomiphene citrate).
- You have unexplained infertility and want to try ovulation induction to increase the number of eggs produced in each cycle. With higher egg production, the chances of conception also increase. In order to benefit from ovulation induction, you must have a normal uterine cavity and at least one normal fallopian tube and your partner must have a normal sperm count.
READY TO DO
THE FIRST STEP?
Whether you are a woman or a man, fill in your MPA pre-interview form without obligation.

FOR man
- TREATMENTS
MEDICAL - Correction
surgical - ICSI
- MPA
MEDICAL
- Antibiotics to treat an infection of the urogenital system.
- Hormones in cases where the testicle does not receive sufficient stimulation from pituitary hormones.
surgical
- Surgical intervention for excretory azoospermia. When a man has this problem, the testicles produce sperm, but it is not present in the ejaculate because there is an obstruction somewhere along the way. Surgery is used to identify the obstruction, remove it and reconnect the segments.
- Surgery may be attempted to cut the obstructed area and restore continuity of the two segments.
- Intracytoplasmic Sperm Injection (ICSI): This is a treatment that is only performed in the context of in vitro fertilisation (IVF). It is used in severe cases of male infertility, when there are not enough sperm cells and they are not mobile enough to penetrate the egg. Using a sample of the spouse's sperm, the embryologist injects a spermatozoon captured with a glass needle with a microscopic diameter into each of the spouse's eggs.
- Percutaneous Epididymal Sperm Aspiration (PESA): This is a treatment only performed in the context of in vitro fertilisation (IVF). Performed under local anaesthesia, this procedure is carried out in cases of obstruction of the vas deferens. Most often, this involves a puncture in the epididymis using a fine needle. However, a small incision in the epididymis is sometimes necessary. Sperm are then collected and the best of these are used for IVF with microinjection.
- Testicular Sperm Extraction (TESE): This is a treatment only performed in the context of in vitro fertilisation (IVF) with ICSI. This procedure, performed under local anaesthetic, involves removing sperm directly from the testicles using a very fine needle. This technique is used when there is a complete absence of sperm in the ejaculate or epididymis, but the testicles are still producing sperm.
- Artificial insemination with spousal sperm (IAC).
- Artificial insemination with donor sperm (AID).
- In vitro fertilisation with spouse's sperm.
- In vitro fertilisation with donor sperm.
More information on treatments
For an informed decision...
Artificial insemination is the most classic and also the simplest of the assisted reproduction techniques. It consists of introducing the man's sperm into the cervical canal or inside the woman's uterus on the day of ovulation. The first step is to monitor the menstrual cycle in order to know the day of ovulation. To do this, serial ultrasound scans and hormonal determinations are carried out.
For artificial insemination, sperm must also be prepared in advance. This involves obtaining the sperm in advance and carrying out capacitation (also known as enhancement) in the laboratory, in order to obtain the best possible quality sperm.
This technique can be repeated several times, but it has been shown that its effectiveness decreases considerably from approximately the fourth attempt onwards, so it is not cost-effective to continue in this way and other treatments should be offered.
IN VITROFERTILISATION
IVF involves the union of gametes (sperm and egg) by placing them in a culture medium. The resulting embryo is transferred immediately in utero or frozen. To give IVF the best chance of achieving pregnancy, several embryos are created. Laboratory technicians are responsible for selecting the embryos to be re-implanted. The embryos are classified according to their appearance, the progress of their cell division, etc. Thus, the 4a, four-cell, round-looking embryos are selected as a priority. When the mother is less than 38 years old, 2 to 3 embryos are re-implanted. When she is over this age, 3 to 4 embryos will be transferred into the maternal uterus.
IVF can be performed in a spontaneous cycle provided it is normal.
INTRACYTOPLASMIC SPERM INJECTION (ICSI)
This technique is in fact assisted in vitro fertilisation. The steps for collecting gametes are identical to those of IVF. It is the technique of "making" the embryo that differs. For ICSI, a micro-pipette loaded with a single spermatozoon is introduced into the egg using a retention pipette.
A single sperm is selected and transferred directly into an oocyte (obtained by means of a containment pipette). The embryo is then transferred to the uterus.
The first step in treatment, in many cases, is pharmacological treatment to induce ovulation.
When indicated, artificial insemination is usually combined with ovulation induction and is often the first procedure used, because it is a simple and economical technique. It is also useful when a (small) alteration is detected in the semen sample, in some cases of female factor and in some mixed causes.
In vitro fertilisation (IVF) will be necessary when a fallopian tube blockage has been diagnosed (this is also why it is used when a child is desired after a tubal ligation), when there are very few sperm available from the man or when a pregnancy is not achieved after several attempts at artificial insemination
More than half of all couples with more than two years of infertility eventually achieve a pregnancy. With advances in research and greater availability of the latest techniques, the success rate of treatments is constantly increasing.
Phenotypic traits considered are eye colour, hair colour and texture, skin colour, Rh factor, height and weight.
INFORMATION REQUEST
DR LADIKPO
Gynecologist-obstetrician
Dr JLADIKPO is an obstetrician-gynecologist with over 10 years' practical experience. She holds a Diplôme d'Etudes Spécialisées in Gynecology-Obstetrics, a Diplôme Universitaire de l'Infertilité et Aide Médicale à la Procréation from the Université Paris Descartes and a Diplôme Universitaire de Colposcopie et Pathologie Cervico-vaginale from the Université d'Angers.
She has several training courses to her credit, notably in Sexual and Reproductive Health Rights and in Health Human Resources Management. She will join PROCREA's dynamic team on May 02, 2023.
DR. GLIDJA RODRIGUE ANGES KOSSI
PEDIATRIC
Dr. Glidja is a pediatrician with 10 years of experience in the field of general pediatrics. With international experience in the sub-region, he works with patients from diverse backgrounds and cultures. Along with from his DES in Paediatrics at the Faculty of Health Sciences of the University of Lomé, he has several training courses under his belt, notably in the field of Tuberculosis and Communication Techniques.
He will join the dynamic team of the PROCREA Clinic on January 10, 2022.
DR. HONORINE HENRI JEAN RENÉ
Medical Director
Doctorate in Medicine, Faculty of Medicine, Abidjan. He previously held the positions of Advisor to the Deputy Technical and Commercial Director, Head of the Health and Social Protection Department at SIDAM, and Resident Doctor at La Madone Clinic from 1988 to 1998.
DR. OUSSOU CLÉMENT
Obstetrician Gynecologist Associate Sonographer
Clément Oussou is an associate doctor and one of the consultant specialists in obstetrics and gynaecology and is also a specialist in video surgery.
- Graduate in Endoscopic Surgery in Gynaecology and Human Reproduction (University of Yaoundé I - Cameroon)
- European postgraduate diploma in gynaecological endoscopy (University of Auvergne Clermont-Ferrand I - France)
- Graduate in hysteroscopy, genital endoscopy and cervico-vaginal pathologies (Pierre and Marie Curie University Paris VI - France)
- Graduate in medicine and reproductive biology (Pierre and Marie Curie University Paris VI - France)
- Graduate in health management (African Centre for Management and Executive Development: CAMPC Abidjan - Ivory Coast)
- Member of the Society of Gynecologists and Obstetricians of Côte d'Ivoire since 2004
- Foreign Corresponding Member of the National College of French Gynaecologists and Obstetricians since February 12th 2013.
DR.Amos
Dr. Amos-Djoro
is a specialist in general medicine with over 35 years of experience in the field.
practice in the field. He graduated from the Faculty of Medicine in Tours, France.He practiced medicine in a multidisciplinary health center in the Cher
in the Cher department and then in a medical centre in the Nièvre department, between
1996 and 2021. With this long experience as a general practitioner, he joins PROCRÉA clinic on October 1st 2022 as Head of the General Medicine Department.
Dr. NASSIROU ADEBAYO FAISSAL
PEDIATRIST - Head of Paediatrics
Dr Nassirou is a paediatrician with more than 15 years of experience in the field of neonatology and paediatrics in general. In addition to the DES in Medical Paediatrics and Childcare, he has several diplomas to his credit, including a DES in Bacteriology and Virology from the University of Félix Houphouët in Abidjan, a DIU (post-graduate diploma) in Perinatal Endocrinology from the University of Paris Saclay and a training course in Resuscitation of the newborn from the University of Aix-Marseille -Provence Medical Relations.
He joined PROCREA Clinic on November 1st 2021 as Head of the Paediatric Department.
DR NOEl KOUASSI
Physician / Intensive care anesthesia
Dr JOEL KOUASSI holds a doctorate in medicine, a state diploma, a certificate of specialized study in anesthesia resuscitation and a university diploma in disaster medicine.
He joined the procréa clinic on January 02, 2023 as a resident anesthetist with 28 years' experience in anesthesia and intensive care.
Dr. Mariame SAKO
Gynecologist - General practitioner
Dr. Mariame SAKO holds a doctorate in medicine from the Free Faculty of Medicine of Lille. During her studies she specialized in emergency and disaster medicine and medical gynecology among others, with an experience of more than 10 years in the mentioned fields.
Dr. Marie JEANSON
General Practitioner - Aesthetic Physician
Dr. Marie JEANSON holds a diploma of specialized study in
General Medicine from the Université Paris Est Créteil. During her studies, she specialized in aesthetic and reparative facial injections at Paris Descartes University.
She joins the PROCRÉA clinic on March1, 2023 as a resident general practitioner on the inpatient ward.
Dr. Ahoui KONAN
Chief Pharmacist
Dr. Ahoui KONAN holds a doctorate degree in pharmacy from the University Félix Houphouët Boigny of Abidjan in 2008. He worked as a pharmacist assistant from 2008 to 2010, then as a civil servant from 2010 to 2014, and as a pharmacist from 2014 to 2021. On March 1, 2023 he joined PROCREA clinic as Chief Pharmacist.
Mrs. KARIDIATA KONE
Midwife
Mrs. KARIDIATA KONE is a midwife with a state diploma in INFAS since 1990, trained by the World Bank on the quality of services delivered in health facilities; she is a referent trainer of midwives and quality supervisor for the district of Cocody-Bingerville. She has 33 years of experience.
DR. Mantary SOUMAHORO
Pharmacist Biologist - Qualitician
Dr. Mantary SOUMAHORO is a pharmacist-biologist and quality control specialist.
She holds a PhD in Pharmacy and a DU in Quality Assurance of Medicines from the Faculty of Medicine and Pharmacy of Rabat, with a ten-year seniority.
During her studies, she specialized in Clinical Biology:
DES in Clinical Biology from the University Félix Houphouët of Abidjan, and in AMP: DU in Infertility Gynecology and AMP from the University Paris Cité.
She will join PROCREA on SEPTEMBER 1, 2022 as a Pharmacist-Biologist and Deputy Head of MPA activities.
DR. JOSE AMOS DJORO
General Practitioner / Head of the General Medicine Department
Dr Amos-Djoro is a specialist in general medicine with more than 35 years of experience in the field. He graduated from the Faculty of Medicine in Tours, France, and practiced medicine in a multidisciplinary health center in the Cher region and then in a medical center in the Nièvre region between 1996 and 2021. With this long experience as a general practitioner, he joins PROCRÉA clinic on October 1st 2022 as Head of the General Medicine Department.
Dr. Myriam KADIO-MOROKRO
Reproductive biologist
General Manager of the PROCREA Clinic, Vice-president of the LYA Foundation - living with sickle cell disease
Holder of a Doctorate of Medicine from the Faculty of Medicine of Abidjan since 2000, Myriam Kadio-Morokro then enrolled in the Training and Research Unit of Medicine Pierre and Marie Curie - Paris XIII from where she obtained the diploma Medicine and Biology of Reproduction in 2003.
With this diploma and after further training in Paris, she returned to Côte d'Ivoire in 2005. She is first head of the classical biological analysis laboratory of the BLEUETS medical center in Abidjan.
Then in 2008, she created with 2 other partners the Ivorian company of hospital management (SIGH), a limited company with a board of directors which is in charge of the PROCREA clinic, the first fertility center with Ivorian capital;
For the past 10 years, she has been the General Manager and responsible for the general strategy of the clinic. She also works as a reproductive biologist.
With her expertise in reproductive health, she participated in 2009 in the creation of GIERAF (Inter African Group for Study, Research and Application on Fertility) with 8 African countries. She was the General Secretary for 4 years.
PROCREA clinic has obtained the GIERAF label since April 2019. Indeed, GIERAF has validated during an audit, the quality approach of the processes in Medical Assistance to Procreation, in accordance with international standards required making the clinic the1st fertility center to have been labeled in Côte d'Ivoire.
In 2019, she obtained the Executive Must certificate on the management of a strategic unit delivered by HEC Paris.
Leader in its field in Côte d'Ivoire. It organizes in October 2022, the inauguration of its new clinic; PROCREA 2. Meeting international norms and standards, it will be better equipped and more capable of receiving all men and women from Africa and elsewhere in search of a parental project. This field of activity requires know-how, confidence and experience.
In parallel to these medical activities, and touched by the disease of one of her relatives and with a purely humanitarian aim, Dr. Kadio-Morokro decided with a group of people to participate in the creation of the LYA FOUNDATION - living with sickle cell disease, which contributes through its action to a better management of sickle cell disease
She has been its President since 2021. She is involved in field actions and projects on sickle cell disease.
Its experience is associated with the mobilization of concerned persons, public authorities, health professionals and social-health actors.